Latest News
News
Teprotumumab gets FDA go-ahead for thyroid eye disease
It is the first drug to be approved for treatment of the debilitating, autoimmune condition.
News from the FDA/CDC
Washington state patient is first U.S. case of novel coronavirus
Conference Coverage
Renal denervation rebounds
The catheter-based intervention is making a comeback – and not just for hypertension.
Feature
Medscape survey points to generational differences in physician burnout
Pulmonology specialists reported a burnout rate of 41%.
Feature
Alan Alda, Scripps Research join forces to improve science communication
LA JOLLA, CALIF. – “Curiosity is the key to staying alive,” the iconic actor said. “That would bring us to a point of more people understanding...
Feature
Cognitive screening of older physicians: What’s fair?
A new report leads to questions about how to standardize the process rather than have a piecemeal institutional approach and whether to focus less...
News
FDA approves CV disease benefit for once-weekly semaglutide
The approval was based on data from the SUSTAIN 6 in patients with type 2 diabetes and established heart disease.
Conference Coverage
Sarcopenia associated with increased cardiometabolic risk
LOS ANGELES – Loss of lean body mass and function with aging reduces metabolically active tissue, which can lead to...
Conference Coverage
Framingham: Exercise lessens cardiometabolic risk of poor diet
PHILADELPHIA –
Latest News
Fewer interventions after sleeve gastrectomy vs. Roux-en-Y, real-world data show
Balanced by weight loss and health outcomes data, safety results may help inform decision making for prospective patients and physicians,...
Conference Coverage
Bariatric surgery is most effective early in the diabetes trajectory
LOS ANGELES – But in the United States, only about 1% of eligible patients with diabetes undergo the procedure.